Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 31, 2008

View Archived Issues

Snapshots on the GlaxoSmithKline's antimalarial vaccines under clinical development in children

Recent clinical study results for anticoagulant DU-176b

Recent patents impart novel anticancer agents

TorreyPines describes new agents for Alzheimer's disease in recent patent

Dr. Reddy's patents novel antibacterial agents

Novocell and Pfizer enter collaboration for pancreatic progenitor cells derived from hES cells

Development of TPI-1020 in COPD discontinued

Oncolytics completes patient enrollment in REO-010 and REO-008 clinical trials of Reolysin

Pfizer and Celldex amend ACT III phase Ib/III clinical trial of CDX-110 in GBM

Genmab and GSK amend worldwide agreement to codevelop and commercialize Arzerra

AMAG receives complete response letter from FDA for ferumoxytol in kidney disease

TopoTarget reports further results from three phase II studies of NAD+ inhibitor APO-866

Phase II study of catumaxomab in gastric cancer meets primary endpoint

Evolva files CTA in Germany for phase I study of EV-077-3201-2TBS

BioCryst reports data for forodesine HCl in chronic lymphocytic leukemia

NPS commences phase III REPLACE study for NPSP-558 in hypoparathyroidism

Sanofi-aventis presents results from DIONYSOS trial in atrial fibrillation

AstraZeneca receives complete response letter for Seroquel XR for MDD

Northwest reports positive results from phase I/II clinical of DCVax-L in ovarian cancer

European Commission grants marketing authorization to Celgene's Vidaza in MDS and AML

Neuren discontinues Glypromate development following pivotal trial

Intercell initiates phase II trial for Pseudomonas aeruginosa vaccine

King commences phase II T-62 trial in neuropathic pain

Phase I study shows HA-22 highly active in hairy cell leukemia

Celsentri tablets approved in Japan for HIV

Addition of BSI-201 to gemcitabine/carboplatin feasible in triple negative breast cancer

Phase I and II data on trastuzumab-DM1 in HER2+ breast cancer reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...